Evercore ISI lowered the firm’s price target on Intuitive Surgical (ISRG) to $480 from $550 and keeps an In Line rating on the shares as part of the firm’s medical technology and life science tools Q1 preview.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Private Markets: Kraken pauses IPO plans, Quince raises $500M
- IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
- Intuitive Surgical: Stapler Reload Recall Seen as Contained, Buy Rating Reaffirmed
- Intuitive Surgical recalls curved-tip surgical staplers, says FDA
- Intuitive Surgical price target lowered to $550 from $570 at UBS